Oligodendrogliomas: Molecular Biology and Treatment-Reference-Cited by-同舟云学术

Oligodendrogliomas: Molecular Biology and Treatment

Published:2009-01-31 Issue:2 Volume:14 Page:155-163
ISSN:1083-7159
Container-title:The Oncologist
language:en
Short-container-title:

Author:

Bromberg Jacolien E. C.¹,van den Bent Martin J.¹

Affiliation:

1. Neuro-Oncology Unit, Daniel den Hoed Cancer Center/Erasmus University Medical Center, Rotterdam, The Netherlands

Abstract

Learning Objectives Evaluate the current challenges in the histological diagnosis of oligodendroglial tumors and apply best practices to optimize patient outcomes. Analyze the molecular alterations in different subsets of tumors with oligodendroglial morphology. Formulate treatment options for your patients with newly diagnosed and recurrent oligodendroglial tumors. This article is available for continuing medical education credit at CME.TheOncologist.com.

Publisher

Oxford University Press (OUP)

Subject

Cancer Research,Oncology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1634/theoncologist.2008-0248

Reference65 articles.

1. Chemotherapy for anaplastic oligodendroglioma;National Cancer Institute of Canada Clinical Trials Group;J Clin Oncol,1994

2. Response rate and prognostic factors of recurrent oligodendroglioma treated with procarbazine, CCNU, and vincristine chemotherapy;Dutch Neuro-oncology Group;Neurology,1998

3. Molecular genetic analysis of oligodendroglial tumors shows preferential allelic deletions on 19q and 1p;Reifenberger;Am J Pathol,1994

4. Localization of common deletion regions on 1p and 19q in human gliomas and their association with histological subtype;Smith;Oncogene,1999

5. Alterations of chromosome arms 1p and 19q as predictors of survival in oligodendrogliomas, astrocytoma, and mixed oligoastrocytomas;Smith;J Clin Oncol,2000

Cited by 67 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Diffuse Astrocytic and Oligodendroglial Tumors;Surgical Neuro-Oncology;2024

2. Case report: ISL2 is involved in malignant transformation in a patient with multiple relapsed oligodendroglioma;Frontiers in Oncology;2022-07-28

3. The correlation analysis of TERT promoter mutations with IDH1/2 mutations and 1p/19q detected in human gliomas;Medicine;2022-07-22

4. Clinical Profile, Pathology, and Molecular Typing of Gliomas with Oligodendroglial Morphology: A Single Institutional Experience;Neurology India;2022

5. Activity of Wnt/PCP Regulation Pathway Classifies Patients of Low-Grade Glioma Into Molecularly Distinct Subgroups With Prognostic Difference;Frontiers in Oncology;2021-09-01